Prevalence and risk factors of Occult Hepatitis C infections in blood donors from Mexico City-Reference-Cited by-同舟云学术

Prevalence and risk factors of Occult Hepatitis C infections in blood donors from Mexico City

Published:2018-10-19 Issue:10 Volume:13 Page:e0205659
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Martínez-Rodríguez María de la Luz^ORCID,Uribe-Noguez Luis A.,Arroyo-Anduiza Carla I.,Mata-Marin José Antonio,Benitez-Arvizu Gamaliel,Portillo-López María L.,Ocaña-Mondragón Alicia

Funder

Consejo Nacional de Ciencia y Tecnología Fondos FOSSISS

Fondos de Investigación en Salud IMSS proyectos

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Hepatitis C: global epidemiology and strategies for control;S Lanini;Clin Microbiol Infect,2016

2. World Health Organization [Internet]. Global hepatitis report; c2017 [Cited 2018 Jun 12]. http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/

3. Frequency of hepatitis C virus infection in a single institution in Mexico with a focus on birth-cohort population;H Baptista-Gonzalez;Ann Hepatol,2016

4. Epidemiology of viral hepatitis in Mexico;A Panduro;Salud Publica Mex,2011

5. ICTV Virus Taxonomy Profile: Flaviviridae;P Simmonds;J Gen Virol,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on Viral Hepatitis B and C in Mexico: Advances and Pitfalls in Eradication Strategies;Microorganisms;2024-07-03

2. Occult liver disease: A multinational perspective;Annals of Hepatology;2024-05

3. Occult hepatitis C infection identified in injection drug users with direct antiviral agents therapy and spontaneous resolution of hepatitis C virus infection;Virus Research;2023-05

4. Hepatitis C virus among blood donors in Lubumbashi, DRC: Seroprevalence and molecular characterisation;Transfusion Clinique et Biologique;2023-05

5. Occult hepatitis C infection: viruses with infectious potential in Huh7.5 and MDBK cell lines suggest HCV/OCI transmission;Pharmacy & Pharmacology International Journal;2023-01-09